Statement of Support

Statement of Support

Testimony of Ethan Nadelmann in Support of a Heroin-assisted Treatment Pilot Program in Nevada

April 7, 2015

On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development Committee. Nadelmann also submitted complementary written testimony. SB275 would create a four-year heroin-assisted treatment pilot program—the first in the United States. Heroin-assisted treatment is a feasible, effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs have failed.

Riverside County School Districts Letter

March 17, 2014

To highlight the atrocities that have gone on in Riverside County high schools and hopefully prevent future ones, the Drug Policy Alliance sent this letter to 20 school district superintendents in Riverside County urging them not to allow undercover law enforcement operations on their campuses.  Such operations are ineffective at combating drug availability on campus and worse, they inflict irreparable harm on young people struggling with the challenges of adolescence or special needs.  The letter also informed schools about the potential legal liability for allowing such operatio

Recommendations for California Byrne Grant Spending

April 30, 2013

DPA’s specific recommendations are to increase the Byrne Grant funding for substance use treatment, reduce funding for activities that arrest people for low-level drug offenses, and to eliminate the funding for marijuana suppression activities. Historically, Byrne Grants have been used primarily to finance drug task forces, which have a record of racially disproportionate low-level drug arrests and increased local and state costs with no measurable impact on public safety.

ONDCP Statement from Director Gil Kerlikowske on ythe Role of Naloxone in Opioid Overose Fatality Prevention

April 12, 2012

Statement from the Director of the Office of National Drug Control Policy stating that the Obama Administration recognizes the important role naloxone can play in reversing drug overdoses.

American Medical Association Resolution on Nasal Naloxone for the Reversal of Opioid Overdose

Resolution stating that the AMA supports the use of nasal naloxone by medical first responders and trained non-medical personnel for the life-saving reversal of opioid overdose. The AMA is committed to advocating for the routine education of all patients receiving prescription opioids, all patients at risk for opioid overdose, and their caregivers in the signs and symptoms of opioid overdose. The AMA also calls for the use of nasal naloxone in the reversal of opioid overdose; and advocates for the routine prescription of nasal naloxone to all patients at risk for opioid overdose.

American Public Health Association Policy Statement on Preventing Overdose Through Education and Naloxone Distribution

October 30, 2012

APHA policy statement includes recommendation for education and access to naloxone.

American Society of Addiction Medicine Statement on the Use of Naloxone for the Prevention of Drug Overdose Deaths

April 1, 2010

ASAM statement recommends the increased use of naloxone and broadened accessibility of naloxone, including to family members.

Statement from Detective Gary Martin in support of North Carolina's Good Samaritan Bill

Detective Gary Martin of the Palm Beach County Sheriff's Office championed Florida's Good Samaritan bill.  Here, he descibes the Palm Beach County Sheriff's Dept.'s findings on local drug overdose deaths and explains his support for Good Samaritan policies from a law enforcement perspective.

Massachusetts Department of Public Health Information Sheet on Massachusetts Good Samaritan Bill

March 20, 2009

This information sheet from the Massachusetts Dept. of Health describes the need for and benefit of a Good Samaritan law in the state.

National Alliance of State & Territorial AIDS Directors Statement On Promoting Injection Drug User Health

August 5, 2011

National Alliance of State & Territorial AIDS Directors Statement of Commitment on Promoting Injection Drug User Health. States that in addition to becoming infected with HIV and viral hepatitis, people who inject drugs are fatally overdosing at elevated rates, and that expanded federal investment in disease and overdose prevention, care and treatment programs is paramount.

Page 1 of 2
Syndicate content